In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Pediatrix trades near fair value with modest 1.6% implied upside, supported by high-confidence DCF and analyst targets, but wide Monte Carlo valuation range ($10-$205) signals high volatility and downside risk (60%). Strong profitability (5/5) contrasts with weak growth (2/5), indicating stable earnings amid growth challenges. Balance of valuation methods reflects cautious optimism amid market uncertainty.